The significantly higher expression of PHLDA2 was observed in multiple cancers, including BRCA, CESC, CHOL, COAD, ESCA, GBM, HNSC, KIRC, LIHC, LUAD, LUSC, PAAD, READ, STAD, THCA, UCEC (all p < 0.05), and lower expression of PHLDA2 was only observed in KICH (p < 0.05) (Fig. 1A). Here, PHLDA2 is linked to cancer.